Literature DB >> 31841191

MiR-141 promotes cell proliferation and invasion in non-small cell lung cancer by targeting KLF9.

Y-J Kong1, X-X Tan, Y Zhang, Q-J He, L Zhao, Q Meng.   

Abstract

OBJECTIVE: Non-small cell lung cancer is the cancer with the highest mortality rate in the whole world. MicroRNA-141 (miR-141) has been reported to be an abnormal expression in multiple tumors including in non-small cell lung cancer. The aim of this study was to verify the potential roles of miR-141 in non-small cell lung cancer and evaluate the effects on cell proliferative and invasive abilities. PATIENTS AND METHODS: MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) and transwell assays were conducted to calculate the tissues and cell lines' proliferative and invasive abilities. Real Time-quantitative Polymerase Chain Reaction (RT-qPCR) and Western blotting were utilized to evaluate the mRNA and protein levels of specific genes.
RESULTS: MiR-141 was significantly upregulated, while krüppel-like factor 9 (KLF9) downregulated in non-small-cell lung cancer (NSCLC) tissues and cell lines. MiR-141 and KLF9 mRNA levels had a negative correlation in NSCLC tissues. The overexpression of miR-141 promoted the proliferation and invasion of A549 cells, while caused contrast results when knockdown miR-141. In addition, KLF9 was a direct target gene of miR-141 and KLF9 partially reversed the roles of miR-141 in A549 cells. MiR-141 promoted the proliferation and invasion by binding to KLF9 in NSCLC.
CONCLUSIONS: MiR-141 promoted the proliferation and invasion by targeting the KLF9 in non-small cell lung cancer, and the newly identified miR-141/KLF9 axis provides novel insight into the pathogenesis of non-small cell lung cancer.

Entities:  

Year:  2019        PMID: 31841191     DOI: 10.26355/eurrev_201912_19676

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  A ratiometric electrochemical DNA-biosensor for detection of miR-141.

Authors:  Ali Khodadoust; Navid Nasirizadeh; Ramezan Ali Taheri; Mohammad Dehghani; Mostafa Ghanei; Hasan Bagheri
Journal:  Mikrochim Acta       Date:  2022-05-05       Impact factor: 5.833

2.  MicroRNA-374b-5p Functions as a Tumor Suppressor in Non-Small Cell Lung Cancer by Targeting FOXP1 and Predicts Prognosis of Cancer Patients.

Authors:  Jianzhao Li; Xinfang Zhang; Jiaying Tang; Cuixue Gong
Journal:  Onco Targets Ther       Date:  2020-05-15       Impact factor: 4.147

3.  miR-196b-5p Promotes Proliferation, Migration and Invasion of Lung Adenocarcinoma Cells via Targeting RSPO2.

Authors:  Qian Xu; Zhenwu Xu
Journal:  Cancer Manag Res       Date:  2020-12-29       Impact factor: 3.989

4.  KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.

Authors:  Jiahua Xing; Ziqi Jia; Yichi Xu; Muzi Chen; Zheng Yang; Youbai Chen; Yan Han
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Circular RNA UBR1 promotes the proliferation, migration, and invasion but represses apoptosis of lung cancer cells via modulating microRNA-545-5p/SSFA2 axis.

Authors:  Peng Su; Feng Mao; Jian Zhang; Hui Zhang; MingBo Wang; YanZhao Xu; ZiQiang Tian
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Mxi1 participates in the progression of lung cancer via the microRNA-300/KLF9/GADD34 Axis.

Authors:  Yujie Lei; Yunchao Huang; Jianbin Lin; Shihui Sun; Keda Che; Junting Shen; Jun Liao; Yangming Chen; Kai Chen; Zhaoxian Lin; Xing Lin
Journal:  Cell Death Dis       Date:  2022-05-02       Impact factor: 8.469

7.  Circular RNA_0078767 upregulates Kruppel-like factor 9 expression by targeting microRNA-889, thereby inhibiting the progression of osteosarcoma.

Authors:  Qiu Chen; Haishen Zhou; Weihao Rong
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

Review 8.  The role of miR-200 family in the regulation of hallmarks of cancer.

Authors:  Klaudia Klicka; Tomasz M Grzywa; Aleksandra Mielniczuk; Alicja Klinke; Paweł K Włodarski
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.